U.S. Physical Therapy Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Chris Reading

Directeur général

US$3.4m

Rémunération totale

Pourcentage du salaire du PDG	28.4%
Durée du mandat du directeur général	20yrs
Propriété du PDG	0.6%
Durée moyenne d'occupation des postes de direction	6.7yrs
Durée moyenne du mandat des membres du conseil d'administration	17.2yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Chris Reading a-t-elle évolué par rapport aux bénéfices de U.S. Physical Therapy?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Sep 30 2024	n/a	n/a	US$14m
Jun 30 2024	n/a	n/a	US$16m
Mar 31 2024	n/a	n/a	US$18m
Dec 31 2023	US$3m	US$959k	US$18m
Sep 30 2023	n/a	n/a	US$24m
Jun 30 2023	n/a	n/a	US$26m
Mar 31 2023	n/a	n/a	US$28m
Dec 31 2022	US$2m	US$926k	US$29m
Sep 30 2022	n/a	n/a	US$39m
Jun 30 2022	n/a	n/a	US$38m
Mar 31 2022	n/a	n/a	US$37m
Dec 31 2021	US$4m	US$896k	US$31m
Sep 30 2021	n/a	n/a	US$31m
Jun 30 2021	n/a	n/a	US$30m
Mar 31 2021	n/a	n/a	US$32m
Dec 31 2020	US$3m	US$676k	US$32m
Sep 30 2020	n/a	n/a	US$30m
Jun 30 2020	n/a	n/a	US$31m
Mar 31 2020	n/a	n/a	US$29m
Dec 31 2019	US$3m	US$769k	US$31m
Sep 30 2019	n/a	n/a	US$30m
Jun 30 2019	n/a	n/a	US$23m
Mar 31 2019	n/a	n/a	US$18m
Dec 31 2018	US$3m	US$739k	US$17m
Sep 30 2018	n/a	n/a	US$18m
Jun 30 2018	n/a	n/a	US$22m
Mar 31 2018	n/a	n/a	US$21m
Dec 31 2017	US$2m	US$720k	US$22m

Rémunération vs marché: La rémunération totale de Chris ($USD 3.37M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché German ($USD 1.64M ).

Rémunération et revenus: La rémunération de Chris a augmenté de plus de 20 % tandis que les bénéfices de l'entreprise ont chuté de plus de 20 % au cours de l'année écoulée.

PDG

Chris Reading (60 yo)

20yrs

Titularisation

US$3,372,377

Compensation

Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer of US Physical Therapy Inc. since November 1, 2004 and serves as its Chairman since May 21, 2024 and served as its Pres...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Christopher Reading	Chairman & CEO	20yrs	US$3.37m	0.63% € 9.0m
Eric Williams	President & COO	3.3yrs	US$1.79m	0.098% € 1.4m
Carey Hendrickson	Chief Financial Officer	4yrs	US$1.69m	0.14% € 2.0m
Richard Binstein	Executive VP	13.8yrs	US$1.50m	0.085% € 1.2m
Graham Reeve	Chief Operating Officer - West	6.7yrs	US$1.91m	0.13% € 1.9m
Jake Martinez	Senior Vice President of Finance & Accounting	2.6yrs	pas de données	pas de données
Chadd Pence	Senior Vice President of Information Systems	no data	pas de données	pas de données
Jayne Pool	Senior VP & Chief Compliance Officer	no data	pas de données	pas de données
Jason Anderson	Vice President of Human Resources	no data	pas de données	pas de données
Jon Bates	VP & Corporate Controller	18yrs	pas de données	pas de données

6.7yrs

Durée moyenne de l'emploi

60yo

Âge moyen

Gestion expérimentée: L'équipe dirigeante de UPH est chevronnée et expérimentée (6.7 années d'ancienneté moyenne).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Christopher Reading	Chairman & CEO	20yrs	US$3.37m	0.63% € 9.0m
Nancy Ham	Independent Director	1.5yrs	US$215.92k	0.0074% € 104.5k
Clayton Trier	Independent Director	19.8yrs	US$269.29k	0.043% € 603.6k
Bernard Harris	Lead Independent Director	19.3yrs	US$264.29k	0.11% € 1.6m
Kathleen Gilmartin	Independent Director	6.5yrs	US$256.54k	0.13% € 1.8m
Reginald Swanson	Independent Director	17.2yrs	US$236.54k	0.13% € 1.8m
Anne Motsenbocker	Independent Director	2.8yrs	US$239.04k	0.037% € 528.4k

17.2yrs

Durée moyenne de l'emploi

67yo

Âge moyen

Conseil d'administration expérimenté: Le conseil d'administration de la UPH est chevronné et expérimenté ( 17.2 années d'ancienneté moyenne).

U.S. Physical Therapy Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

President & COO recently sold €179k worth of stock

Chairman & CEO recently sold €196k worth of stock

Chief Operating Officer - East recently sold €242k worth of stock

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Chief Operating Officer - West recently sold €253k worth of stock

Chief Operating Officer - West recently sold €413k worth of stock

Recent updates

President & COO recently sold €179k worth of stock

Third quarter dividend of US$0.44 announced

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

Now 21% undervalued after recent price drop

Chairman & CEO recently sold €196k worth of stock

Chief Operating Officer - East recently sold €242k worth of stock

First quarter dividend of US$0.44 announced

First quarter 2024 earnings released: EPS: US$0.54 (vs US$0.58 in 1Q 2023)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Chief Operating Officer - West recently sold €253k worth of stock

Fourth quarter dividend of US$0.44 announced

New minor risk - Profit margin trend

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$1.99 (vs US$2.25 in FY 2022)

Now 21% undervalued

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Now 21% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: US$0.62 (vs US$0.72 in 3Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Chief Operating Officer - West recently sold €413k worth of stock

Second quarter 2023 earnings released: EPS: US$0.80 (vs US$0.87 in 2Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

First quarter 2023 earnings released: EPS: US$0.57 (vs US$0.67 in 1Q 2022)

Independent Director recently sold €439k worth of stock

Executive VP recently sold €87k worth of stock

Upcoming dividend of US$0.43 per share at 1.7% yield

Full year 2022 earnings released: EPS: US$2.25 (vs US$2.42 in FY 2021)

U.S. Physical Therapy, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Independent Director recently sold €573k worth of stock

President recently sold €858k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million.

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice for $25 million.

Insufficient new directors

Upcoming dividend of US$0.41 per share

Chief Operating Officer - West recently sold €162k worth of stock

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: US$0.73 (vs US$0.66 in 3Q 2021)

U.S. Physical Therapy, Inc. Provides Operating Guidance for 2022

U.S. Physical Therapy, Inc. (NYSE : USPH) acquired 60% stake in Fourteen-clinic physical therapy practice for $19.3 million.

U.S. Physical Therapy, Inc. to Report Q3, 2022 Results on Nov 03, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Two-Clinic Physical Therapy Practice for $4.2 million.

Director recently bought €78k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania for $3.5 million.

Independent Director recently bought €82k worth of stock

Independent Director recently bought €54k worth of stock

Second quarter 2022 earnings released: EPS: US$0.86 (vs US$0.82 in 2Q 2021)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 16, 2022

U.S. Physical Therapy, Inc. to Report Q2, 2022 Results on Aug 04, 2022

First quarter 2022 earnings released: EPS: US$0.68 (vs US$0.21 in 1Q 2021)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on June 14, 2022

Insufficient new directors

U.S. Physical Therapy, Inc. to Report Q1, 2022 Results on May 05, 2022

U.S. Physical Therapy, Inc., Annual General Meeting, May 17, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in Madden and Gilbert Physical Therapy, LP from Chad Madden, Michael Gilbert and others for $11.5 million.